We are live on ! Find out more
PSTV icon

Plus Therapeutics
PSTV

3 hedge funds and large institutions have $33.4M invested in Plus Therapeutics in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $32.1M → $33.4M (+$1.28M)

0% more funds holding

Funds holding: 3 → 3 (0)

70% less call options, than puts

Call options by funds: $164K | Put options by funds: $542K

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$164K
Puts
$542K
Net Calls
-$378K
Net Calls Change
+$208K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
-$143K
2
SIP
Stoneridge Investment Partners
Pennsylvania
-$134K
3
Principal Financial Group
Principal Financial Group
Iowa
-$59K
4
RCM
Rotella Capital Management
Washington
-$48K
5
PC
Passport Capital
California
-$42K
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
51
T. Rowe Price Associates
Maryland
$44K – – –
BNP Paribas Financial Markets
52
BNP Paribas Financial Markets
France
$39.1K – – –
Citigroup
53
Citigroup
New York
$39K – – –
DADC
54
D.A. Davidson & Co
Montana
$39K – – –
Mitsubishi UFJ Asset Management
55
Mitsubishi UFJ Asset Management
Japan
$35K – – –
JP Morgan Chase
56
JP Morgan Chase
New York
$34K – – –
Goldman Sachs
57
Goldman Sachs
New York
$30K – – –
TC
58
TFS Capital
Pennsylvania
$29K – – –
Mariner
59
Mariner
Kansas
$28K – – –
OC
60
Oppenheimer & Co
New York
$28K – – –
SG Americas Securities
61
SG Americas Securities
New York
$27K – – –
Bank of America
62
Bank of America
North Carolina
$24K – – –
VKH
63
Virtu KCG Holdings
New York
$23K – – –
Ameriprise
64
Ameriprise
Minnesota
$14K – – –
ST
65
Spot Trading
Illinois
$11K – – –
Barclays
66
Barclays
United Kingdom
$7K – – –
MWAM
67
Mariner Wealth Advisors (Madison)
Kansas
$5K – – –
BlackRock
68
BlackRock
New York
$4K – – –
Manulife (Manufacturers Life Insurance)
69
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$120 – – –
UB
70
UMB Bank
Missouri
$84 – – –
GGHC
71
Gilder Gagnon Howe & Co
New York
– -$143K – –
Hudson Bay Capital Management
72
Hudson Bay Capital Management
Connecticut
– -$37K – –
LTFS
73
Ladenburg Thalmann Financial Services
Florida
– -$5K – –
PC
74
Passport Capital
California
– -$42K – –
Principal Financial Group
75
Principal Financial Group
Iowa
– -$59K – –
1 2
3
4

PSTV Hedge Fund Activity: Q3 2013 in Review

3 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q3 2013, worth a combined $33.4M — up 4% from $32.1M a quarter earlier.

Fund positioning in PSTV was balanced in Q3 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $143K.

  • 3 institutional investors held Plus Therapeutics (PSTV) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $33.4M of Plus Therapeutics stock for Q3 2013, up 4% quarter-over-quarter.
  • 0 funds opened new Plus Therapeutics positions in Q3 2013 and 0 closed out.
  • The largest Plus Therapeutics seller in Q3 2013 was Gilder Gagnon Howe & Co, an estimated $143K sold.

Based on aggregated 13F filings for Q3 2013.